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Abstract Biochemical and genetic data on the metabolism of 
inositol phosphates in the microorganism Dictyostelium are 
combined in a scheme composed of in five subroutes. The first 
subroute is the inositol cycle as found in other organisms: inositol 
is incorporated into phospholipids that are hydrolysed by PLC 
producing Ins(l,4,5)P3 which is dephosphorylated to inositol. 
The second subroute is the sequential phosphorylation of inositol 
to InsP6; the Ins(3,4,6)P3 intermediate does not release Ca
2+. 
The third subroute is the sequential phosphorylation of 
Ins(l,4,5)P3 to InsP6 in a nucleus associated fraction, whereas 
the fourth subroute is the dephosphorylation of Ins(l,3,4,5,6)P5 
to Ins(l,4,5)P3 at the plasma membrane. This last route mediates 
Ins(l,4,5)P3 formation in cells with a disruption of the single 
PLC gene. Finally, we recognize the formation of InsP7 and 
InsPg as the fifth subroute. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Dictyostelium is a fungus that diverted from the evolution-
ary mainstream about 1 billion years ago, after the diversion 
of yeast but before the splitting between animals and plants 
[1]. The amoeboid cells live in the soil where they feed on 
bacteria. When the bacteria become scarce, starvation induces 
the expression of a cAMP sensory system; some cells start to 
secrete cAMP to which cells in the surrounding respond with 
a chemotactic reaction. A cell aggregate is formed that can be 
composed of up to 100000 cells. Finally, a fruiting body is 
formed consisting of spores embedded in a slime droplet on 
top of highly vacuolized cells arranged in a stalk. When food 
is available, spores germinate and amoebae will search for 
food by chemotaxis. 
Extracellular cAMP stimulates several second messengers 
pathways, including adenylyl cyclase, guanylyl cyclase, phos-
pholipase C, and the opening of plasma membrane Ca2+ 
channels. Directed cell locomotion and specific gene expres-
sion are the two main cellular responses induced by extracel-
lular cAMP. Cells possess surface receptors that bind cAMP. 
Four genes encoding cAMP receptors have been identified 
(see [2]). The deduced amino acid sequences predict that 
they pass the membrane seven times, typical for receptors 
that interact with G-proteins. Dictyostelium contains only 
one gene encoding a Gp subunit. Cells with a deletion of 
GP are strongly defective in many responses, including the 
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activation of adenylyl cyclase, guanylyl cyclase, phospholipase 
C, chemotaxis and gene expression [3]. Interestingly, the 
cAMP-mediated opening of Ca2+ channels still occurs in cells 
lacking Gp, suggesting that this response is G-protein-inde-
pendent [4]. The Dictyostelium genome uncovers eight genes 
encoding Get subunits [5]; their function in regulating PLC is 
described below. 
The metabolism of inositol phosphates is very complex, and 
Dictyostelium is not an exception. Mass detection has identi-
fied at least 25 compounds in this organism, with relatively 
large concentrations of InsPg, InsP7 and InsPg [6]. In this 
review inositol phosphate metabolism will be subdivided in 
eight parts, and some attention will be paid to their localiza-
tion in the cell and their regulation. A division is made into 
(1) de novo synthesis of inositol, (2) conversion of inositol to 
phospholipids in membranes, (3) formation of Ins(l,4,5)P3 
from PtdIns(4,5)P2 by phospholipase C, (4) degradation of 
Ins(l,4,5)P3 to inositol in the cytosol, (5) sequential phospho-
rylation of inositol to InsP6 in the cytosol, (6) formation of 
Ins(l,4,5)P3 from Ins(l,3,4,5,6)P5 by a new enzyme at the 
plasma membrane, (7) phosphorylation of Ins(l,4,5)P3 to 
InsPf, in the nucleus, and finally the formation of higher in-
ositol phosphates such as InsP7 and InsPg (see Fig. 1). 
2. De novo synthesis of inositol and formation of inositol 
phospholipids 
Dictyostelium cells can grow on a semi-synthetic defined 
medium that does not include inositol [7], indicating that cells 
can make this sugar. The precursor is most likely glucose 6-
phosphate that is converted to Ins3P and subsequently de-
phosphorylated to inositol, as in other organisms [8]. No ex-
perimental evidence for the presence of an Ins3P synthase is 
available, except that introduction of [14C]glucose into cells by 
electroporation results in the formation of small amounts of 
[14C]InsPe (Van Haastert, unpublished observations); it is 
known that InsP6 is formed mainly from inositol via Ins3P 
(see below). 
When [3H]inositol is introduced into Dictyostelium cells by 
electroporation, the label is rapidly converted to Ptdlns reach-
ing a maximum after 10 min [9,10]. It then takes a relatively 
long time to form PtdIns4P (maximal after 45 min), which is 
converted within 15 min to PtdIns(4,5)P2. Except for devel-
opmentally regulated Ptdlns 4-kinase [11], little is known 
about the enzymes involved in inositol phospholipid metabo-
lism. 
A family of five phosphatidylinositol kinases (PIK) have 
been cloned in Dictyostelium by Zhou et al. [12]. PIK5 shows 
high homology with the family of yeast Vsp34p and presum-
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ably phosphorylate Ptdlns at the 3-position. Such an enzyme 
was suggested by the detection of small amounts of PtdIns3P 
in Dictyostelium [13]. Reduced expression of PIK5 leads to 
slow growth and abnormal development. PIK4 encodes a pu-
tative Ptdlns 4-kinase; attempts to disrupt the gene were un-
successful, suggesting that it might be essential for growth. 
PIK1, PIK2 and PIK3 are most closely related to pi 10 Ptdlns 
3-kinase that use PtdIns4P and PtdIns(4,5)P2 as substrates. 
Disruption of a single PIK1, PIK2, or PIK3 gene has no 
effect, while double knockouts PIK1/PIK3 or PIK2IPIK3 ap-
pear to be lethal. The double knockout PIK1IPIK2 grows 
slowly and shows abnormal development. When these cells 
are labelled with 32PC>4, reduced levels of PtdInsP3 are ob-
served without alterations of PtdIns(3,4)P3 levels [14]. A 
PtdIns4P 5-kinase has not been identified yet. 
3. Phospholipase C 
3.1. Regulation of phospholipase C 
PLC is present mainly in the plasma membrane and to 
some extend in the cytosol and in a nuclear fraction. The 
enzyme is strictly Ca2+-dependent with half-maximal stimula-
tion at about 0.5 uM Ca2+ [15,16]. In cells, cAMP stimulates 
PLC enzyme activity about 2-fold. Regulation of PLC activity 
was studied in detail using mutants with deletions of genes 
encoding specific cAMP receptors (cAR) and Ga subunits. 
Activation of PLC by cAMP does not require cARl, and 
probably also not cAR3 [17]. Some cAMP analogues that 
previously were shown to be chemotactic antagonists, inhibit 
PLC activity; this inhibition requires cARl expression. In a 
cell-free extract GTPyS stimulates PLC activity. Stimulation 
of PLC by cAMP in cells or by GTPyS in lysates is lost in 
mutants with a deletion of the Ga2 gene, suggesting that 
activation of PLC is mediated by an unknown cAMP receptor 
and the G-protein G2. Inhibition of PLC by cAMP antago-
nists is lost in cells with a deletion of the Gal gene. Thus, it is 
suggested that inhibition of PLC by cAMP occurs via cARl 
and Ga l [17]. 
3.2. Phospholipase C gene and protein 
One gene encoding phosphatidylinositol-specific phospho-
lipase C (Dd-PLQ has been identified in Dictyostelium [18]. 
Mammalian cells possess three classes of PLC isozymes that 
all require Ca2+ ions for full activity [19,20]. PLC|3 is regu-
lated by G-proteins; PLCy contains SH2 and SH3 domains 
and is activated by tyrosine kinase receptors. Regulation of 
enzymes of the PLC8 class is largely unknown; it has been 
suggested that only Ca2+ ions regulate enzyme activity. The 
deduced primary sequence of Dd-PLC places it in the class of 
PLC5 isozymes. Cells with an inactivated Dd-PLCh gene have 
lost all detectable PLC activity [6]. Also extended searches by 
PCR or low-stringency hybridization does not give any indi-
cation for another PLC gene. 
Using the three-dimensional structure of mammalian PLC 
[21], the deduced primary sequence of Dd-PLC8 can now be 
interpreted. The N-terminal segment of about 300 amino acids 
is composed of a PH-domain and four EF-hands domains. 
This is followed by a split catalytic domain; all eukaryotic 
PLC isozymes have an insertion in the catalytic domain of 
variable length and function. At the C-terminus of Dd-
PLC8, a conserved C2 domain is recognized that may help 
in binding of the enzyme to the membrane [22]. In rat PLC8 
135 amino acids can be deleted from the N-terminus without 
loss of activity [23], but this is probably not the case in Dic-
tyostelium where deletion of 44 amino acids leads to inactiva-
tion of the enzyme (Drayer et al., unpublished observations). 
The insertion in the catalytic domain of Dd-PLC8 is predicted 
to be a strong EF-hand Ca2+-binding domain. Mutations of 
those amino acids that would chelate the Ca2+ ion have no 
effect on the Ca2+-sensitivity of the enzyme, but lead to re-
duced maximal PLC activity; apparently this Ca2+ fulfills a 
structural role and is not the Ca2+ site of regulating the ac-
tivity of PLC [16]. Deletion of small parts of the C-terminal 
segment of Dd-PLC8 destroys enzyme activity; a similar ob-
servation was made for rat PLC8 [23]. 
3.3. Deletion of phospholipase C gene 
Unexpectedly, cells with a disruption of the Dd-PLCb gene 
grow with the same rate as wild-type cells, they show chemo-
taxis and differentiate without observable defects. Even more 
unexpectedly, cells contain nearly normal Ins(l,4,5)P3 levels as 
measured using mass assays, although they have no detectable 
PLC activity [6]. On further analysis, we observed in 
[3H]inositol-labelled cells that [3H]Ins(l,4,5)P3 has very low 
specific activity in the plc-null mutant and thus was formed 
from a source that is not rapidly labelled with [3H]inositol. In 
wild-type and plc-null cells [3H]inositol is rapidly converted to 
[3H]PtdIns(4,5)P2 (see above in Section 2) and only slowly to 
[3H]InsP6 via the de novo synthesis route (see below in Sec-
tion 5). In wild-type cells [3H]Ins(l,4,5)P3 has approximately 
the same specific activity as its presumed precursor 
[3H]PtdIns(4,5)P2. The relatively cold [
3H]Ins(l,4,5)P3 in plc-
null cells and the reduced mass of Ins(l,3,4,5,6)P5 in this 
mutant [6] led to the speculation that a phosphatase acting 
on higher inositol phosphates may mediate Ins(l,4,5)P3 syn-
thesis in cells lacking PLC activity (see below in Section 6). 
4. Degradation of Ins(l,4,5)P3 
Ins(l,4,5)P3 is degraded in the cytosol of Dictyostelium cells 
by two phosphatases at the 5- and 1-position, respectively 
[24]. Mammalian cells only possess a 5-phosphatase, whereas 
plants have only the 1-phosphatase [25]. In growing Dictyo-
stelium cells, both enzymes are present, but the 5-phosphatase 
disappears during multicellular differentiation [26]. As the 5-
phosphatase does not degrade Ins(l,3,4,5)P4, the enzyme may 
be a type-II 5-phosphatase as classified in mammalian cells 
[27]. The products of Ins(l,4,5)P3 degradation, Ins(l,4,)P2 
and Ins(4,5)P2, are both dephosphorylated to Ins4P, which 
is further degraded to inositol. 
At least three InsP isomers are produced in Dictyostelium 
via different routes. InslP is formed from the phospholipid 
Ptdlns by a phospholipase C reaction, Ins4P is formed by 
degradation of Ins(l,4,5)P3, whereas Ins3P is formed by de 
novo synthesis from glucose 6-phosphate or by phosphoryla-
tion of inositol. Specific enzymes and HPLC were used to 
discriminate between these isomers [28]. Pulse-labeling of cells 
with [3H]inositol reveals that InslP is the first labelled InsP 
isomer, followed by Ins4P, whereas almost no Ins3P is 
formed; this kinetics of InsP formation is consistent with 
the extremely rapid formation of [3H]PtdIns, the slower for-
mation of [3H]PtdIns(4,5)P2 and [
3H]Ins(l,4,5)P3, and the still 
slower phosphorylation of inositol to [3H]Ins3P. 
Inositol monophosphatases are generally inhibited by lith-
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Fig. 1. Scheme of inositol phosphate metabolism in Dictyostelium. A: The overall scheme, depicting the numbered subroutes, their location 
(c = cytosol; n = nucleus; m = plasma membrane), and the main compounds. B: All reaction steps and intermediates. 
ium in an uncompetitive mechanism, which has been used to 
explain the therapeutic effects of lithium [29]. In mammalian 
cells one lithium-sensitive monophosphatase degrades all InsP 
isomers [30]. Dictyostelium contains three enzymes that de-
grade InsP isomers with very different substrate specificity 
and sensitivity to lithium [28]. The first enzyme is similar to 
the mammalian enzyme as it is inhibited by lithium and hy-
drolyses both InslP, Ins4P and to a lesser extend Ins3P. The 
second enzyme only hydrolyses Ins4P and is not inhibited by 
lithium, whereas the third enzyme is also lithium-insensitive 
and degrades especially Ins3P and also InslP and Ins4P. Lith-
ium has diverging effects on the relative levels of InsP iso-
mers: inositol levels are hardly affected, InslP is increased 
to 600%, Ins4P to 190%, whereas Ins3P levels were reduced 
to 72%o. These data are consistent with the specificity and 
relative sensitivity to lithium of the three monophosphatases 
in Dictyostelium [28]. Clearly, the monophosphatase activity is 
not the target of lithium for its pronounced effects during 
development of this organism [31]. 
5. Sequential phosphorylation of inositol to InsP6 
Incubation of the cytosol with inositol and ATP results in 
the formation of large amounts of InsPe [32]. The first step is 
the synthesis of Ins3P by a myo-inositol D-3 hydroxykinase 
[13]. The phosphorylation of Ins3P to InsP6 is strictly sequen-
tial, with the intermediates Ins(3,6)P2, Ins(3,4,6)P3, 
Ins(l,3,4,6)P4, and Ins(l,3,4,5,6)P5. Thus, the InsP3 isomer 
is different from the important Ins(l,4,5)P3 that is produced 
by phospholipase C and liberates Ca2+ from internal stores. 
The InsPs isomer appears to be an important compound be-
cause it intersects with several other metabolic routes (see 
Fig. 1 and below). 
In cell lysates InsPg is rapidly dephosphorylated to 
Ins(l,2,4,5,6)P5 and Ins(l,2,3,4,6)Ps, and rephosphorylated 
to InsP6 [32]. It has been calculated that these in vitro enzyme 
activities are sufficiently high to give half-times of conversions 
to InsP6 for Ins(l,2,4,5,6)P5 and Ins(l,2,3,4,6)P5 in the order 
of 0.8 and 6.4 s, respectively. As the concentration of these 
InsP5 isomers are 20^-0 uM, these dephosphorylation/phos-
phorylation shunts would consume relevant amounts of en-
ergy [32]. Van der Kaay et al. [33] have tried to find evidence 
for the presence of these shunts in vivo by incubating cells 
with 32P-labeled inorganic phosphate, isolating [32P]InsP6, and 
determining which position of InsP6 is labelled. It was ob-
served that after a short incubation of cells with 32P, InsP^ 
was predominantly labelled at the 6-position, whereas the 4-
and 5-positions were relatively cold. Thus, no indications 
for the proposed futile InsPs/InsPo cycles were found in vivo 
[33]. 
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6. Formation of Ins(l,4,5)P3 from Ins(l,3,4,5,6)PB at the 
plasma membrane 
Cells with a deletion of the single PLC gene have nearly 
normal Ins(l,4,5)P3 levels, suggesting that another route for 
the formation of Ins(l,4,5)P3 must exist, at least in Dictyo-
stelium. Several higher inositol phosphates with phosphates at 
the 1-, 4-, and 5-positions were tested as potential substrates 
for the formation of Ins(l,4,5)P3 in cell lysates [34]. Small 
amounts of Ins(l,4,5)P3 are produced from InsPe; 
Ins(l,2,3,4,5)P5 and Ins(l,2,4,5,6)P5 are not converted to 
Ins(l,4,5)P3. The only InsPs isomer that is a very good sub-
strate for Ins(l,4,5)P3 production in lysates from bothplc-null 
and wild-type cells is Ins(l,3,4,5,6)P5, which is the same InsPs 
isomer with reduced mass in plc-null cells. The intermediate 
products of the reaction are Ins(l,3,4,5)P4 and Ins(l,4,5,6)P4, 
both compounds are degraded to Ins(l,4,5)P3 [26]. This deg-
radation of Ins(l,3,4,5,6)P5 at the 3- and 6-positions is most 
likely mediated by one enzyme [35]. 
The enzyme is strictly Ca2+-dependent with half-maximal 
activity at 0.9 uM Ca2+ for all substrates. Cell fractiona-
tion studies demonstrate the enzyme to be localized at the 
inner face of the plasma membrane. Interestingly, the 
Ins(l,3,4,5,6)P5 3/6-bisphosphatase is activated by the surface 
cAMP receptor; activation probably occurs via the elevation 
of intracellular Ca2+ mediated by opening of a plasma mem-
brane Ca2+ channel, since activation is absent when extracel-
lular Ca2+ is removed [35]. 
Mammalian cells contain an enzyme called multiple inositol 
polyphosphate phosphatase (MIPP) that shows some resem-
blance with the Dictyostelium enzyme [34,36]. Both enzymes 
use Ins(l,3,4,5,6)P5 as substrate and produce Ins(l,4,5)P3. 
However, the main mammalian enzyme from rat liver prefer-
entially dephosphorylates at the 3-position. Furthermore, the 
mammalian enzyme resides in the endoplasmatic reticulum 
where it has no excess to its substrate [36]. An Ins(l,3,4,5)P4 
3-phosphatase has been detected in human erythrocytes that is 
present at the plasma membrane and dependent on Ca2+ ions 
as the Dictyostelium enzyme [37]. It is possible that mamma-
lian cells may contain two MIPP isozymes, a Ca2+-independ-
ent enzyme localized in the ER, and a Ca2+-dependent en-
zyme at the plasma membrane. 
Dictyostelium cells have two routes to make Ins(l,4,5)P3, 
via PLC and via a Ins(l,3,4,5,6)Ps 3/6-bisphosphatase. In cells 
with a blockade of the PLC route Ins(l,4,5)P3 levels are 
maintained using the second route. The observation that 
out of 20 inositol phosphates only Ins(l,3,4,5,6)Ps levels are 
reduced in plc-mx\\ cells suggest that this phosphatase route 
of Ins(l,4,5)P3 formation is recruited in the mutant to 
maintain Ins(l,4,5)P3 levels. Does this redundancy mean 
that Ins(l,4,5)P3 (and thus PLC) is very important, or is 
Ins(l,4,5)P3 one of the many inositol phosphate metab-
olites that has no role in signal transduction? Inac-
tivation of the 3/6-bisphosphatase gene may answer this ques-
tion. 
7. Phosphorylation of Ins(l,4,5)P3 to InsP6 in the nucleus 
When investigating the phosphorylation of inositol phos-
phates, we observed that both inositol and Ins(l,4,5)P3 can 
be converted to InsP6 in cell lysates [33]. Careful cell lysis and 
fractionation reveals phosphorylation of inositol to take place 
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in the cytoplasm as described by Stephens and Irvine [13,32], 
whereas phosphorylation of Ins(l,4,5)P3 occurs only in a nu-
cleus-associated fraction of the cell lysate. In order to observe 
enzyme activity, the nuclei should be broken, suggesting that 
the enzymes are localized inside the nucleus or the nuclear 
envelope [33]. Ins(l,4,5)P3 is phosphorylated first at the 3-
position, then at the 6-position and finally at the 2-position. 
It is not known how Ins(l,4,5)P3 and its products enter or 
leave the nuclear compartment. One may suggest via the nu-
cleopore, but incubation of isolated nuclei with [3H]H20 and 
[32P]Ins(l,4,5)P3 reveals the rapid equilibration of 3H-label 
whereas the 32P-label is excluded from the nucleus (Van Dij-
ken, Van der Kaay and Van Haastert, unpublished observa-
tions). 
Using the same nuclear preparations, we have detected sev-
eral enzyme activities in broken nuclei, including Ptdlns kin-
ases, PLC and Ins(l,4,5)P3 phosphatases. This suggest that 
the nucleus or a nucleus-associated fraction contains nearly 
all enzyme activities. 
8. InsP7 and InsP8 
Dictyostelium cells contain relatively large amounts of two 
inositol phosphates that elute from ion-exchange columns 
after InsP6 [38,39]. Their identification was performed using 
NMR and specific enzymes; InsP7 is D-6-PP-InsPs, whereas 
InsPg was identified as D-5,6-bis-PP-InsP4 [40]. The route of 
InsP7 formation is not known; InsPg is derived from InsP7 by 
a 5-kinase. The pyrophosphates in InsPy and InsPg probably 
have a high energy potential. Vogelmaier et al. demonstrated 
that the phosphorylation of InsP6 to InsPj by a purified rat 
kinase can run in reverse, transferring a phosphate group to 
ADP to form ATP [41]. 
9. Conclusions 
The metabolism of inositol phosphate in Dictyostelium is 
slowly emerging. This organism contains a single PLC gene 
belonging to the PLC5 class. Yeast and probably plants also 
possess only a PLC5; apparently PLCP and PLCy isozymes 
and expansion of the three subtypes to a very large family 
took place after the diversion of plants and animals. Two 
routes for the formation of Ins(l,4,5)P3 have been identified, 
PtdIns(4,5)P2-PLC and Ins(l,3,4,5,6)P5-3/6-bisphosphatase. 
These two routes are likely to be present in animals, where 
the InsP5-phosphatase may contain subtypes that are localized 
in different cellular compartments. The function of higher in-
ositol phosphates are still poorly understood. Isolation of 
mutants with altered metabolism may uncover the function 
of these compounds. The identification of the main routes 
of formation and degradation of InsP6, InsP7 and InsPg in 
Dictyostelium is an important first step towards understanding 
the function of these compounds that attain such high con-
centrations in many cells. 
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